Structure-Based Discovery of BM-957 as a Potent Small-Molecule Inhibitor of Bcl-2 and Bcl-xL Capable of Achieving Complete Tumor Regression
Author:
Affiliation:
1. Comprehensive Cancer Center and Departments of Internal Medicine, Pharmacology and Medicinal Chemistry and ‡Life Sciences Institute, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-0934, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm3010306
Reference40 articles.
1. Apoptosis in cancer
2. Apoptosis-based therapies
3. The Hallmarks of Cancer
4. From bench to clinic with apoptosis-based therapeutic agents
5. Bcl-2-regulated apoptosis: mechanism and therapeutic potential
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL;Nature Communications;2024-03-29
2. B‐cell lymphoma‐2 family proteins in the crosshairs: Small molecule inhibitors and activators for cancer therapy;Medicinal Research Reviews;2023-11-20
3. Benzimidazol-2-ylidene ruthenium complexes for C-N bond formation through alcohol dehydrogenation;Turkish Journal of Chemistry;2023-10-31
4. N-Methyl-N-arylformamides: Synthesis and Interaction of with Carbonic Anhydrase (PDB: 3FW3) and Nuclease (PDB: 6O70) Enzymes via In Silico Molecular Docking;Russian Journal of General Chemistry;2023-01
5. Cascade reaction of 3-formylchromones: Highly selective synthesis of 4-oxo-3-(1H-pyrrol-3-yl)-4H-chromenes;Green Synthesis and Catalysis;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3